<DOC>
	<DOCNO>NCT01245335</DOCNO>
	<brief_summary>Critical Limb Ischemia prevents legs foot receive oxygen nutrient need proper function . This severe lack blood flow lead painful legs walk rest result foot sore , ulcer , gangrene , even amputation . The purpose study determine injection concentrate bone marrow damage tissue result improve blood flow . If successful , treatment could improve blood flow lower limb , reduce pain , reduce frequency limb amputation .</brief_summary>
	<brief_title>Bone Marrow Aspirate Concentrate ( BMAC ) Treatment Critical Limb Ischemia ( CLI )</brief_title>
	<detailed_description>Bone marrow aspirate collect processed centrifugation remove red blood cell . The result concentrate cell injected ischemic tissue low limb . The purpose study determine injection concentrate bone marrow nucleate cell ischemic tissue result vasculogenesis .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Patient Peripheral Arterial Occlusive Disease ( PAOD ) clinical Rutherford Category 5 disease , define reporting standard adopt Society Vascular Surgeons ( table 1 ) ; Minor Tissue lossfocal gangrene diffuse pedal ischemia Patient meet least one follow diagnostic criterion study limb : Ankle artery occlusion pressure absolute ≤60 mmHg ABI ≤0.6 Toe artery occlusive pressure &lt; 50mm Hg TBI ≤0.6 There reasonable open surgical endovascular revascularization option determine treat vascular specialist . Factors may contribute determination inoperability may include : Anatomical consideration No outflow target No appropriate conduit ( i.e . vein bypass ) Long segment occlusion calcify lesion predict poor outcome endovascular approach . High risk medical condition i.e . Unstable cardiac disease . History prior fail revascularization attempt The Patient 's case review treat institution 's Multidisciplinary Vascular Conference patient 's status poor candidate conventional therapy confirm . Age ≥18 year ability understand plan treatment Subject read sign IRB approve Informed Consent form Patients follow medication ( ) prescribe must one month stable baseline therapy prior enrollment : Plavix/asprin therapy , anticoagulation therapy , cholesterol lower agent , blood pressure medication . If medication prescribe notation reason omission provide . Hematocrit ≥ 28.0 % , White Blood Cell count ≤ 14,000 , Platelet count ≥ 50,000 , Creatinine ≤ 2.5 mg / dL , INR ≤ 1.6 unless Coumadin , PTT &lt; 1.5 x control ( avoid bleeding complication ) Patients Coumadin correct prior procedure must INR &lt; 1.6 time randomization/surgery . Life expectancy &lt; 6 month due concomitant illness History bone marrow disease ( especially NHL , MDS ) prohibit transplantation Terminal renal failure exist dependence dialysis serum creatinine &gt; 2.5 mg/dL Known active malignancy result outside normal limit follow test : PAP , Chest Xray , PSA , Mammogram , Hemocult unless followup study reveal patient cancer free . Poorly control diabetes mellitus ( HgbA1C &gt; 10 % ) Medical risk precludes anesthesia ( conscious sedation ) , ASA Class 5 Lifethreatening complication ischemia necessitate immediate amputation Uncorrected occlusion common external iliac artery index side Absence pulsatile Doppler flow ankle . Extensive necrosis index limb condition make amputation inevitable ( Rutherford Category 6 ) . Ulceration expose bone proximal distal metatarsal head ( ie . heel mid foot ) Active clinical infection infection treat antibiotic within one week enrollment Treatment immunosuppressant drug ( include Prednisone &gt; 5 mg per day ) . Female pregnant nursing , child bear potential use reliable birth control method . Underwent major open cardiovascular surgical procedure ( carotid endarterectomy , arterial aneurysm bypass surgery , coronary artery bypass surgery ) myocardial infarction within 3 month prior randomization Underwent successful partially successful endovascular intervention peripheral arterial occlusive disease . ( ie . Aorta , iliac , femoral , popliteal , tibial artery angioplasty , stenting , atherectomy ) within prior 3 month . Endovascular coronary intervention ( ie . Angioplasty , atherectomy , stenting ) within 1 month prior randomization . Underwent fail attempt endovascular revascularization prior 1 month . For purpose exclusion criterion endovascular procedure consider failure : 1 . The procedure diagnostic intervention perform , ( example case wire crossing obtain ) . 2 . The treated artery recoil , thromboses , dissects result occlusion treat arterial segment , document intraoperative imaging . Note endovascular procedure suboptimal result meet criterion 1 2 may qualify inclusion 3 month # 16 . Cerebrovascular accident within 6 month prior randomization . Treatment topical growth factor hyperbaric oxygen ( HBO ) within 30 day , systemic growth factor treatment within 6 month enrollment . Known hypersensitivity heparin ; history heparininduced thrombocytopenia ( HIT ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>CLI</keyword>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>PAOD</keyword>
	<keyword>Peripheral Arterial Disease</keyword>
	<keyword>Stem Cells</keyword>
	<keyword>Limb amputation</keyword>
	<keyword>Leg ulcer</keyword>
</DOC>